Stocks TelegraphStocks Telegraph
Stock Ideas

CALT Stock Performance and Key Statistics

NASDAQ : CALT

Calliditas Therapeutics AB (publ)

$40.00
-0.0399-0.10%
At Close 4:00 PM
Not Actively Trading
62.66
BESG ScoreESG Rating

stock performance chart

CALT Fundamental Analysis

Based on recent data, Calliditas Therapeutics AB (publ) (CALT) shows an Average True Range (ATR) of 1.05 and an Enterprise Value of 5.39B. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into CALT's underlying financial health and market activity.

ATR1.05
Enterprise Value5.39B
Avg Vol (3 Months)-
Avg Vol (10 Days)-

CALT Technical Analysis Indicators

Calliditas Therapeutics AB (publ) (CALT) technical indicators as of May 15, 2026: the SMA 20 is -0.76%, SMA 50 at 1.28%, and SMA 200 at 39.49%. The RSI 14 value is 50.49, suggesting its current momentum. These technical analysis signals help assess CALT's price trends and potential future movements.

SMA 20-0.76%
SMA 501.28%
SMA 20039.49%
RSI 1450.49

CALT Stock Performance Overview

Calliditas Therapeutics AB (publ) (CALT) stock performance overview as of May 15, 2026: The 52-week high is N/A (currently -6.98% below), and the 52-week low is N/A (currently 162.3% above). Over the past year, CALT's performance is 146.91%, compared to the S&P 500's 12.09% change.

52-Week HighN/A
52-Week High Chg-6.98%
52-Week LowN/A
52-Week Low Chg+162.30%
S&P 500 52-Week Chg12.09%

Calliditas Therapeutics AB (publ) (CALT) Historical Stock Performance

According to market data, Calliditas Therapeutics AB (publ) (CALT) stock's recent performance metrics show that over the last month, CALT is -1.33%, with a Year-to-Date (YTD) performance of 55.38%. Over the past year, the stock has seen a 146.91% change. These figures summarize CALT's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
HighN/AN/AN/AN/AN/AN/A
LowN/AN/AN/AN/AN/AN/A
Performance0-1.33%+3.28%+87.79%+146.91%+55.38%

Industry Analysis and Valuation

According to current financial data, CALT stock's P/E (TTM) ratio is -21.52, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for CALT, including P/S (16.63), P/B (29.97), and P/FCF (-44.86), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationCALTSector MedianIndustry AvgS&P 500
P/E (TTM)-21.52-1.22-5.1232.59
P/S (TTM)16.633.69464.325.98
P/B (TTM)29.975.1813.844.67
P/FCF (TTM)-44.861009.4-429.132.44

Frequently Asked Questions

How is CALT price-to-earnings ratio currently?
CALT has a current P/E ratio of -21.52
How are CALT's price-to-sale and price-to-book ratios?
The CALT stock has a trailing twelve month price-to sales (P/S) ratio of 16.63 while its price-to-book (P/B) value is 29.97.
Is Calliditas Therapeutics AB (publ)'s price-to-cashflow ratio high or low?
CALT's price-to-free-cashflow (P/FCF) ratio is -44.86, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for CALT?
Based on CALT's recent bid, its distance from 20 days simple moving average is -0.76%. It is 1.28% apart from 50 days simple moving average, and it is 39.49% apart from 200 days simple moving average.
What is the 52-week price range for CALT?
The 52-week high for CALT is $43.00 which is -6.98% away from the current price level whereas the distance of that from the 52-week low of $15.25 stands at 162.3%.
An overview of CALT's stock performance: how did it fare?
The performance of CALT stock was not encouraging with most of its significant price indicators in green. Calliditas Therapeutics AB (publ)(NASDAQ: CALT) shares have moved downward -0.10% or - $0.04 in the latest trading session and have gained 55.38% year-to-date (YTD). The stock has gained nearly 146.91% over the past year. After moving 3.28% over the trailing 3-month period, the stock is 87.79% higher in the 6-month period. Looking at its performance over the shorter term, it'slost 0% a week and -1.33% a month.
What is CALT's 14-day relative strength index (RSI)?
The current 14-day RSI for CALT stock is 50.49. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For CALT, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Calliditas Therapeutics AB (publ) (CALT) has a 14-day ATR of 1.05.
What is CALT's current enterprise value?
After closing at $40.04 with 53.69M of its shares outstanding, the current enterprise value of CALT is roughly 5.39B.
Over the past year, how has the stock price of CALT changed?
Calliditas Therapeutics AB (publ) (NASDAQ: CALT) is up 146.91% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 12.09%. CALT stock price is also up 55.38% on its value in year-to-date trading.
What is the average trading volume for CALT shares?
The number outstanding shares of CALT is 53.69M, and of these 2.5% shares are freely available for trading. On average, CALT stock has traded - shares per day for the past 10 days. A total of 9.8K shares changed hands during the last trading session with the average session volume of 7.73K shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph